Bharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Institute of India, to strengthen production and supply security of oral polio vaccines. An agreement has been signed between the two partners under which Bharat Biotech will procure drug substances for the production of oral polio vaccines (OPVs) to be supplied within India and globally, the company said in a statement.
Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India. This is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company, Biofabri, a press release from Bharat Biotech said.
Bharat Biotech signs MoU with University of Sydney to collaborate on vaccine research
Bharat Biotech picks up 20 per cent stake in Eastman Exports Global Clothing
Singapore's sovereign fund Temasek Holdings is in advanced talks to acquire a minority stake of 15-20% in Cloudnine, a chain of women, childcare & fertility hospitals, said two people aware of the development. Temasek is likely to invest about ?500 crore, valuing the Bengaluru-based hospital chain at ?3,000 crore.
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. He was speaking on the sidelines of an event here at which a bilateral agreement was signed between the University of Wisconsin (UW)-Madison Global Health Institute (GHI) and the Ella Foundation for the establishment of the first-ever UW-Madison One Health Centre in Bengaluru.
As the country marked its 74th Republic Day, Union Health Minister Dr Mansukh Mandaviya and Union Science and Technology Minister Jitendra Singh launched Bharat Biotech's first India-made nasal Covid-19 vaccine, iNCOVACC, on Thursday.
Bharat Biotech-manufactured Incovacc, the world's first nasal Covid-19 vaccine, will be available in private hospitals in the country from next week, people in the know told ET. Incovacc was launched on Thursday by Union health minister Mansukh Mandaviya.
Vaccine maker Bharat Biotech’s subsidiary Chiron Behring Vaccines has initiated a voluntary recall of a specific batch of its rabies vaccine Chirorab.
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. Interacting with students at the India International Science Festival in Bhopal, Ella also said that the homegrown vaccine for the lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month.